Liu et al. [141] showed that inhibiting CD39 in bladder cancer increased tumor-infiltrating NK cells and conventional type 1 dendritic cells (cDC1) and enhanced the cytotoxicity of CD8+ T cells. Here, CD8A is linked to neoplasm.